Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation
Clinical trial NCT02499237 · COMPLETED
Trial details
- NCT number
- NCT02499237
- Sponsor
- 424 General Military Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-11-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.